NCT01677338 - Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

July 31, 2014

Conditions

Dyspeptic Subjects

Interventions

DRUG

13C-uracil

PO, the Semi-solid Test Meal containing 100 mg of 13C-uracil . Perform the Breath Test.

DRUG

99mTc sulfur colloid

PO, the Solid Test Meal containing 500 uCi 99mTc sulfur colloid. Perform the Scintigraphy.

Trial Locations (2)

Compass Research, Orlando

Dartmouth-Hitchcock Medical Center, Gastroenterology and Hepatology, Lebanon